Small for gestational age (SGA) children are more prone to have precocious pubarche and exaggerated precocious adrenarche, an earlier onset of pubertal development and menarche, and faster progression of puberty than children born of appropriate for gestational age (AGA) size. The majority of studies investigating the onset of puberty in children born SGA and AGA established that, although puberty begins at an appropriate time (based on chronological age and actual height) in SGA children, onset is earlier relative to AGA children. Evaluating pubertal growth in SGA children, a more modest bone age delay from chronological age at the onset of puberty and more rapid bone maturation during puberty compared to AGA children were reported. Peak height velocity in adolescence is reached at an earlier pubertal stage and lasts for a shorter period in children born SGA than in those born AGA. These differences lead to an earlier fusion of the growth plates and a shorter adult height. The pathophysiological mechanism underlying the unique pubertal growth pattern of children born SGA remains unclear. However, it seems that this is not only related to birth weight, gestational age, adiposity or obesity, but that there may also be an influence of rapid weight gain in early childhood on pubertal onset: excess weight gain in childhood may be related to central adiposity, decreased insulin sensitivity, and increased IGF-I levels and might thus predispose to precocious pubarche.

Keywords:
Children born light for gestational age, Children born short for gestational age, Growth, Puberty, Adrenarche, Precocious pubarche
1.
Saenger P, Czernichow P, Hughes I, Reiter EO: Small for gestational age: short stature and beyond. Endocr Rev 2007;28:219-251.
2.
Karlberg J, Albertsson-Wikland K: Growth in full-term small-for-gestational-age infants: from birth to final height. Pediatr Res 1995;38:733-739.
3.
Leger J, Levy-Marchal C, Bloch J, Pinet A, Chevenne D, Porquet D, Collin D, Czernichow P: Reduced final height and indications for insulin resistance in 20-year-olds born small for gestational age: regional cohort study. BMJ 1997;315:341-347.
4.
Valuniene M, Danylaite A, Kryziute D, Ramanauskaite G, Lasiene D, Lasas L, Verkauskiene R: Postnatal growth in children born small and appropriate for gestational age during the first years of life (in Lithuanian). Medicina (Kaunas) 2009;45:51-60.
5.
Albertsson-Wikland K, Karlberg J: Natural growth in children born small for gestational age with and without catch-up growth. Acta Paediatr Suppl 1994;399:64-70, discussion 71.
6.
Albertsson-Wikland K, Boguszewski M, Karlberg J: Children born small-for-gestational age: postnatal growth and hormonal status. Horm Res 1998;49:7-13.
7.
Hernandez MI, Mericq V: Pubertal development in girls born small for gestational age. J Pediatr Endocrinol Metab 2008;21:201-208.
8.
Buck Louis GM, Gray LE, Jr., Marcus M, Ojeda SR, Pescovitz OH, Witchel SF, Sippell W, Abbott DH, Soto A, Tyl RW, Bourguignon JP, Skakkebaek NE, Swan SH, Golub MS, Wabitsch M, Toppari J, Euling SY: Environmental factors and puberty timing: expert panel research needs. Pediatrics 2008;121(suppl 3):S192-S207.
9.
Hernandez MI, Mericq V: Impact of being born small for gestational age on onset and progression of puberty. Best Pract Res Clin Endocrinol Metab 2008;22:463-476.
10.
Zhang LH, Rodriguez H, Ohno S, Miller WL: Serine phosphorylation of human p450c17 increases 17,20-lyase activity: implications for adrenarche and the polycystic ovary syndrome. Proc Natl Acad Sci USA 1995;92:10619-10623.
11.
Silfen ME, Manibo AM, Ferin M, McMahon DJ, Levine LS, Oberfield SE: Elevated free IGF-I levels in prepubertal Hispanic girls with premature adrenarche: relationship with hyperandrogenism and insulin sensitivity. J Clin Endocrinol Metab 2002;87:398-403.
12.
Denburg MR, Silfen ME, Manibo AM, Chin D, Levine LS, Ferin M, McMahon DJ, Go C, Oberfield SE: Insulin sensitivity and the insulin-like growth factor system in prepubertal boys with premature adrenarche. J Clin Endocrinol Metab 2002;87:5604-5609.
13.
Ibanez L, Potau N, Zampolli M, Rique S, Saenger P, Carrascosa A: Hyperinsulinemia and decreased insulin-like growth factor-binding protein-1 are common features in prepubertal and pubertal girls with a history of premature pubarche. J Clin Endocrinol Metab 1997;82:2283-2288.
14.
Ibanez L, Potau N, Francois I, de Zegher F: Precocious pubarche, hyperinsulinism, and ovarian hyperandrogenism in girls: relation to reduced fetal growth. J Clin Endocrinol Metab 1998;83:3558-3562.
15.
Ibanez L, Potau N, Marcos MV, de Zegher F: Exaggerated adrenarche and hyperinsulinism in adolescent girls born small for gestational age. J Clin Endocrinol Metab 1999;84:4739-4741.
16.
Ong KK, Potau N, Petry CJ, Jones R, Ness AR, Honour JW, de Zegher F, Ibanez L, Dunger DB: Opposing influences of prenatal and postnatal weight gain on adrenarche in normal boys and girls. J Clin Endocrinol Metab 2004;89:2647-2651.
17.
Ong KK, Ahmed ML, Emmett PM, Preece MA, Dunger DB: Association between postnatal catch-up growth and obesity in childhood: prospective cohort study. BMJ 2000;320:967-971.
18.
Ong K, Kratzsch J, Kiess W, Dunger D: Circulating IGF-I levels in childhood are related to both current body composition and early postnatal growth rate. J Clin Endocrinol Metab 2002;87:1041-1044.
19.
Ong KK, Petry CJ, Emmett PM, Sandhu MS, Kiess W, Hales CN, Ness AR, Dunger DB: Insulin sensitivity and secretion in normal children related to size at birth, postnatal growth, and plasma insulin-like growth factor-I levels. Diabetologia 2004;47:1064-1070.
20.
Francois I, de Zegher F: Adrenarche and fetal growth. Pediatr Res 1997;41:440-442.
21.
Neville KA, Walker JL: Precocious pubarche is associated with SGA, prematurity, weight gain, and obesity. Arch Dis Child 2005;90:258-261.
22.
Veening MA, van Weissenbruch MM, Roord JJ, de Delemarre-van Waal HA: Pubertal development in children born small for gestational age. J Pediatr Endocrinol Metab 2004;17:1497-1505.
23.
Dahlgren J, Boguszewski M, Rosberg S, Albertsson-Wikland K: Adrenal steroid hormones in short children born small for gestational age. Clin Endocrinol (Oxf) 1998;49:353-361.
24.
Eyzaguirre FC, Bancalari R, Youlton R, Roman R, Silva R, Garcia H, Mericq V: Precocious pubarche: experience in 173 cases (in Spanish). Rev Med Chil 2009;137:31-38.
25.
Ibanez L, Ong K, Dunger DB, de Zegher F: Early development of adiposity and insulin resistance after catch-up weight gain in small-for-gestational-age children. J Clin Endocrinol Metab 2006;91:2153-2158.
26.
Ekelund U, Ong KK, Linne Y, Neovius M, Brage S, Dunger DB, Wareham NJ, Rossner S: Association of weight gain in infancy and early childhood with metabolic risk in young adults. J Clin Endocrinol Metab 2007;92:98-103.
27.
Todorova B, Salonen M, Jaaskelainen J, Tapio A, Jaaskelainen T, Palvimo J, Turpeinen U, Hamalainen E, Rasanen M, Tenhola S, Voutilainen R: Adrenocortical hormonal activity in 20-year-old subjects born small or appropriate for gestational age. Horm Res Paediatr 2012;77:298-304.
28.
Karlberg J, Kwan CW, Gelander L, Albertsson-Wikland K: Pubertal growth assessment. Horm Res 2003;60:27-35.
29.
Albertsson-Wikland K, Karlberg J: Natural growth in children born SGA with and without catch-up growth. Horm Res 2003;59 suppl 1):129.
30.
Persson I, Ahlsson F, Ewald U, Tuvemo T, Qingyuan M, von Rosen D, Proos L: Influence of perinatal factors on the onset of puberty in boys and girls: implications for interpretation of link with risk of long term diseases. Am J Epidemiol 1999;150:747-755.
31.
Lazar L, Pollak U, Kalter-Leibovici O, Pertzelan A, Phillip M: Pubertal course of persistently short children born small for gestational age (SGA) compared with idiopathic short children born appropriate for gestational age (AGA). Eur J Endocrinol 2003;149:425-432.
32.
Chaudhari S, Otiv M, Hoge M, Pandit A, Mote A: Growth and sexual maturation of low birth weight infants at early adolescence. Indian Pediatr 2008;45:191-198.
33.
Sloboda DM, Hart R, Doherty DA, Pennell CE, Hickey M: Age at menarche: influences of prenatal and postnatal growth. J Clin Endocrinol Metab 2007;92:46-50.
34.
Ghirri P, Bernardini M, Vuerich M, Cuttano AM, Coccoli L, Merusi I, Ciulli C, D'Accavio L, Bottone U, Boldrini A: Adrenarche, pubertal development, age at menarche and final height of full-term, born small for gestational age (SGA) girls. Gynecol Endocrinol 2001;15:91-97.
35.
Bhargava SK, Ramji S, Srivastava U, Sachdev HP, Kapani V, Datta V, Satyanarayana L: Growth and sexual maturation of low birth weight children: a 14-year follow-up. Indian Pediatr 1995;32:963-970.
36.
Ibanez L, Jimenez R, de Zegher F: Early puberty-menarche after precocious pubarche: relation to prenatal growth. Pediatrics 2006;117:117-121.
37.
Koziel S, Jankowska EA: Effect of low versus normal birthweight on menarche in 14-year-old polish girls. J Paediatr Child Health 2002;38:268-271.
38.
Leger J, Limoni C, Collin D, Czernichow P: Prediction factors in the determination of final height in subjects born small for gestational age. Pediatr Res 1998;43:808-812.
39.
Ibanez L, Valls C, Cols M, Ferrer A, Marcos MV, De Zegher F: Hypersecretion of FSH in infant boys and girls born small for gestational age. J Clin Endocrinol Metab 2002;87:1986-1988.
40.
Ibanez L, Potau N, de Zegher F: Ovarian hyporesponsiveness to follicle stimulating hormone in adolescent girls born small for gestational age. J Clin Endocrinol Metab 2000;85:2624-2626.
41.
Hernandez MI, Martinez A, Capurro T, Pena V, Trejo L, Avila A, Salazar T, Asenjo S, Iniguez G, Mericq V: Comparison of clinical, ultrasonographic, and biochemical differences at the beginning of puberty in healthy girls born either small for gestational age or appropriate for gestational age: preliminary results. J Clin Endocrinol Metab 2006;91:3377-3381.
42.
Phillips DJ, Albertsson-Wikland K, Eriksson K, Wide L: Changes in the isoforms of luteinizing hormone and follicle-stimulating hormone during puberty in normal children. J Clin Endocrinol Metab 1997;82:3103-3106.
43.
Wide L, Albertsson-Wikland K, Phillips DJ: More basic isoforms of serum gonadotropins during gonadotropin-releasing hormone agonist therapy in pubertal children. J Clin Endocrinol Metab 1996;81:216-221.
44.
Jensen RB, Vielwerth S, Larsen T, Greisen G, Veldhuis J, Juul A: Pituitary-gonadal function in adolescent males born appropriate or small for gestational age with or without intrauterine growth restriction. J Clin Endocrinol Metab 2007;92:1353-1357.
45.
Ibanez L, Potau N, Enriquez G, de Zegher F: Reduced uterine and ovarian size in adolescent girls born small for gestational age. Pediatr Res 2000;47:575-577.
46.
Ibanez L, de Zegher F: Puberty after prenatal growth restraint. Horm Res 2006;65(suppl 3):112-115.
47.
Ibanez L, Potau N, Enriquez G, Marcos MV, de Zegher F: Hypergonadotrophinaemia with reduced uterine and ovarian size in women born small-for-gestational-age. Hum Reprod 2003;18:1565-1569.
48.
Francois I, de Zegher F, Spiessens C, D'Hooghe T, Vanderschueren D: Low birth weight and subsequent male subfertility. Pediatr Res 1997;42:899-901.
49.
Brown LM, Pottern LM, Hoover RN: Prenatal and perinatal risk factors for testicular cancer. Cancer Res 1986;46:4812-4816.
50.
Michos A, Xue F, Michels KB: Birth weight and the risk of testicular cancer: a meta-analysis. Int J Cancer 2007;121:1123-1131.
51.
Dahlgren J, Albertsson-Wikland K: Final height in short children born small for gestational age treated with growth hormone. Pediatr Res 2005;57:216-222.
52.
Boguszewski M, Rosberg S, Albertsson-Wikland K: Spontaneous 24-hour growth hormone profiles in prepubertal small for gestational age children. J Clin Endocrinol Metab 1995;80:2599-2606.
53.
Boguszewski M, Jansson C, Rosberg S, Albertsson-Wikland K: Changes in serum insulin-like growth factor I (IGF-I) and IGF-binding protein-3 levels during growth hormone treatment in prepubertal short children born small for gestational age. J Clin Endocrinol Metab 1996;81:3902-3908.
54.
Clayton PE, Cianfarani S, Czernichow P, Johannsson G, Rapaport R, Rogol A: Management of the child born small for gestational age through to adulthood: a consensus statement of the international societies of pediatric endocrinology and the growth hormone research society. J Clin Endocrinol Metab 2007;92:804-810.
55.
de Zegher F, Hokken-Koelega A: Growth hormone therapy for children born small for gestational age: height gain is less dose dependent over the long term than over the short term. Pediatrics 2005;115:e458-e462.
56.
van Dijk M, Bannink EM, van Pareren YK, Mulder PG, Hokken-Koelega AC: Risk factors for diabetes mellitus type 2 and metabolic syndrome are comparable for previously growth hormone-treated young adults born small for gestational age (SGA) and untreated short SGA controls. J Clin Endocrinol Metab 2007;92:160-165.
57.
Boonstra V, van Pareren Y, Mulder P, Hokken-Koelega A: Puberty in growth hormone-treated children born small for gestational age (SGA). J Clin Endocrinol Metab 2003;88:5753-5758.
58.
Lem AJ, van der Kaay DC, de Ridder MA, Bakker-van Waarde WM, van der Hulst FJ, Mulder JC, Noordam C, Odink RJ, Oostdijk W, Schroor EJ, Sulkers EJ, Westerlaken C, Hokken-Koelega AC: Adult height in short children born SGA treated with growth hormone and gonadotropin releasing hormone analog: results of a randomized, dose-response GH trial. J Clin Endocrinol Metab 2012;97:4096-4105.
59.
de Zegher F, Lopez-Bermejo A, Ibanez L: Adipose tissue expandability and the early origins of PCOS. Trends Endocrinol Metab 2009;20:418-423.
60.
Ibanez L, Valls C, Ong K, Dunger DB, de Zegher F: Metformin therapy during puberty delays menarche, prolongs pubertal growth, and augments adult height: a randomized study in low-birth-weight girls with early-normal onset of puberty. J Clin Endocrinol Metab 2006;91:2068-2073.
61.
Ong K, de Zegher F, Valls C, Dunger DB, Ibanez L: Persisting benefits 12-18 months after discontinuation of pubertal metformin therapy in low birthweight girls. Clin Endocrinol (Oxf) 2007;67:468-471.
62.
Ibanez L, Lopez-Bermejo A, Diaz M, Marcos MV, de Zegher F: Metformin treatment for four years to reduce total and visceral fat in low birth weight girls with precocious pubarche. J Clin Endocrinol Metab 2008;93:1841-1845.
63.
Ibanez L, Lopez-Bermejo A, Diaz M, Marcos MV, de Zegher F: Early metformin therapy (age 8-12 years) in girls with precocious pubarche to reduce hirsutism, androgen excess, and oligomenorrhea in adolescence. J Clin Endocrinol Metab 2011;96:E1262-1267.
© 2013 S. Karger AG, Basel
2013
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.